MAPT and obesity due to melanocortin 4 receptor deficiency: Moreover, palmitoylated PrRP (palm-PrRP31) analog has been shown to have both anti-obesity and glucose- lowering properties, and it has also been shown to act as a neuroprotective compound in mouse models of Aβ or Tau pathology [33, 34].